On Mar 11, 2026, CURI reported earnings of -0.07 USD per share (EPS) for Q4 25, missing the estimate of -0.03 USD, resulting in a -128.76% surprise. Revenue reached 19.20 million, compared to an expected 19.21 million, with a -0.07% difference. The market reacted with a -2.14% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 5 analysts forecast an EPS of -0.01 USD, with revenue projected to reach 17.30 million USD, implying an decrease of -85.71% EPS, and decrease of -9.89% in Revenue from the last quarter.